Imraldi 40mg Pre-Filled Pen: Uses, Side Effects & Guide
Quick summary: Imraldi 40mg solution for injection in a pre-filled pen is a biosimilar medicine containing adalimumab. It is used for inflammatory conditions and is designed for subcutaneous self-injection after training. This guide explains...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Imraldi 40mg solution for injection in a pre-filled pen is a biosimilar medicine containing adalimumab. It is used for inflammatory conditions and is designed for subcutaneous self-injection after training.
This guide explains what the medicine is, how it is commonly used, possible side effects, what to do if a dose is missed, and what to check about UK pricing.
Medical disclaimer: This article is for general information only and does not replace the patient leaflet, pharmacist advice, or guidance from your prescriber. Always follow the instructions given for your own medicine and condition.
What is Imraldi 40mg solution for injection in a pre-filled pen?
Imraldi is a biosimilar medicine that contains adalimumab. It is used for inflammatory conditions, including rheumatoid arthritis and Crohn’s disease, as described in the original content.
The pre-filled pen format is designed to make subcutaneous injection easier for patients who have been trained to use it. The pen also includes safety features intended to support safer handling.
How Imraldi is used
Imraldi is given as a subcutaneous injection. The original content states that it is typically used every two weeks or as directed by a healthcare provider.
Because injection technique matters, patients are usually shown how to use the pen before self-administration. If you are unsure about any step, check the official instructions supplied with the medicine or ask a pharmacist or nurse.
General injection steps mentioned in the original content
- Let the pen reach room temperature before use, if instructed.
- Clean the injection site with an alcohol pad or wipe.
- Allow the skin to dry fully before injecting.
- Inject at the angle described in the instructions for your pen.
- Dispose of the used pen safely in the correct sharps container.
- Rotate injection sites to help reduce skin irritation.
What to do if you miss a dose
If you forget a dose, the original content advises taking it as soon as you remember unless it is close to the next scheduled dose. In that case, skip the missed dose and return to your usual routine.
Do not double up doses to make up for a missed one. If you are uncertain what to do, check the patient leaflet or contact your healthcare professional.
Possible side effects of Imraldi
Like all medicines, Imraldi can cause side effects. The original content highlights the following:
- Injection site reactions such as redness, swelling, or itching
- Headaches
- Increased risk of infections
Some reactions can be more serious. Seek urgent medical help if you notice signs of a severe allergic reaction, symptoms of infection such as fever or persistent cough, or unusual bruising or bleeding.
When to get medical advice
Contact a healthcare professional promptly if side effects are worrying, persistent, or getting worse. The safest source for side effect details is the official leaflet supplied with the medicine.
How much does Imraldi cost in the UK?
The cost of Imraldi in the UK can vary depending on pharmacy pricing, prescription arrangements, and any insurance or coverage that applies. The original content does not give a fixed price.
If you need current pricing, check with a pharmacist, prescriber, or dispensing service. They can also help you understand whether any coverage or support options apply to your situation.
What to check before using the pen
Before using Imraldi, it is sensible to confirm the following from the leaflet or your healthcare team:
- How often your dose should be taken
- How the pen should be prepared
- Where to inject
- How to store the medicine
- How to dispose of used pens safely
These details can vary by product presentation, so the official instructions are important.
Imraldi and adalimumab
Imraldi contains adalimumab and is described in the original content as a biosimilar medicine. Biosimilars are designed to work similarly to the reference medicine, but patients should still use the exact product prescribed and follow the instructions provided for that specific pen.
Frequently asked questions
▸ How do you use the Imraldi pen?
The original content says to let the pen reach room temperature if instructed, clean the injection site, and inject subcutaneously following the training or leaflet provided with the medicine.
▸ Is Imraldi the same as adalimumab?
Imraldi contains adalimumab and is described as a biosimilar medicine. If you have questions about switching or product differences, check with your prescriber or pharmacist.
▸ What is Imraldi used for?
The original content says it is used for inflammatory conditions, including rheumatoid arthritis and Crohn’s disease.
▸ What should I do if I miss a dose?
Take it when you remember unless it is close to the next dose. If so, skip the missed dose and return to your usual schedule. Do not double the dose.
▸ What side effects are mentioned for Imraldi?
The original content mentions injection site reactions, headaches, and a higher risk of infections. It also notes that severe allergic reactions and signs of infection need urgent attention.
▸ Where can I confirm the correct instructions?
Use the patient leaflet supplied with the medicine and ask a pharmacist, nurse, or prescriber if anything is unclear.
Safety reminder
Always use Imraldi exactly as prescribed and follow the official instructions for your specific pen. If you notice signs of infection, a severe allergic reaction, or any symptom that worries you, seek medical advice promptly.
Note: The video embedded in the original content has not been included here so the article remains clean, accessible, and focused on the written guidance.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
- NHS medicines information: Adalimumab
- Electronic Medicines Compendium: Imraldi
- NHS: How to use an injection pen
- British Society for Rheumatology patient information
- Crohn’s & Colitis UK
To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.